Day: February 15, 2022

Conference Call on Tuesday, March 1, 2022 at 8:30 a.m. ET LEXINGTON, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it will release its fourth quarter and full year 2021 financial results before the market opens on Tuesday, March 1, 2022. Agenus executives will host a conference call and webcast at 8:30 a.m. ET the same day to discuss the results and to provide a corporate update. Conference CallDial-in numbers: (833) 614-1394 (US) or (914) 987-7115 (International) Conference ID: 4651648. WebcastA live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at...

WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that the company is scheduled to present at Aegis Virtual Conference, on Wednesday, February 23rd at 1:30 – 2:00 PM ET. A recording of the presentation will be posted to the Rockwell Medical website after the conference. The presentation will also be available by request to Aegis from February 23rd to 25th, 2022. To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar. About Rockwell Medical Rockwell Medical is a commercial-stage biopharmaceutical...

Expands Clinical Operations Team in Advance of Pivotal Clinical Studies CARLSBAD, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (NASDAQ: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announced today that Robert McRae has joined the senior management team as Senior Vice President, Operations and Strategic Development. Rob is an accomplished industry veteran with a proven track record of execution and will be responsible for internal operations helping set corporate strategy. “Rob’s leadership skills are a great addition to our team to help shape the future of Palisade Bio. His deep understanding and breadth of experiences in biotech operations and strategy will serve Palisade Bio well as we advance LB1148 towards Phase 3 clinical trials,”...

Mauldin, SC , Feb. 15, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC Pink: XCRT) today announced that Fran White has accepted an invitation to join its Advisory Board effective immediately. Fran founded MDC Associates more than 30 years ago. MDC is a consulting company specializing in regulatory affairs management in the medical device and biotechnology industries. Their clients include many of the leading companies in the biotech and diagnostic industries. Prior to founding MDC, Fran held a number of management roles within ThermoFisher, a Fortune 500 world leader in the supply of scientific instrumentation, consumables and software services. “Fran brings another invaluable skill set to our Advisory Board,” said Michael O’Shea, Xcelerate’s CEO. “Fran has more than 40 years’ experience providing companies and investors with insight...

SEATTLE, Feb. 15, 2022 (GLOBE NEWSWIRE) — Jones Soda Co. (OTCQB: JSDA) (“Jones” or the “Company”) is pleased to announce that it completed the previously announced acquisition of all the issued and outstanding common shares (the “Pinestar Shares”) of Pinestar Gold Inc. (the “Pinestar”) by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). As part of the Arrangement, the obligations in respect of each share purchase warrant of Pinestar (including an aggregate of 700,000 warrants that were transferred to Pinestar) were assumed by Jones and each such remaining warrant became exercisable into one share of Jones Common stock at a price of Cdn$0.06 per share. Completion of Concurrent Financing In connection with the Arrangement, Pinestar completed an offering for subscription receipts...

Alto Ingredients, Inc. Appoints New General Counsel New General Counsel Auste M. GrahamSACRAMENTO, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, added Auste M. Graham to the senior management team as General Counsel and Corporate Secretary effective February 1, 2022. Graham reports directly to CEO Mike Kandris and succeeds Christopher Wright, who will remain with the company as Senior Vice President pending his retirement later this year. Kandris said, “Auste has served in legal leadership positions in global manufacturing enterprises in several industries, including specialty chemicals, components and industrial coatings. Her deep experience in commercial affairs and her expertise in corporate securities, M&A...

$SBEV – SFLMaven Sees Weekly Sales Top $202k on Strong Demand and Premium Items 18K gold 10.20CTW VS diamond tennis bracelet, sold for $8,000 at last week’s SFLMaven Famous Thursday Night Auction$SBEV – SFLMaven Sees Weekly Sales Top $202k on Strong Demand and Premium Items Rare vintage Patek Philippe Gondolo watch with onyx dial sold at auction for $6,200FORT LAUDERDALE, FL, Feb. 15, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, is pleased to announce that the Company saw over $202k in total sales for the week ended Thursday, February 10, 2022. The Company’s “Famous Thursday Night Auction” event again dominated sales activity for the week. SFLMaven has now pulled in over...

AUSTIN, Texas, Feb. 15, 2022 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”) a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, will attend the HIMMS Global Health Conference & Exhibition (“HIMMS”), which is being held virtually and in-person at Orlando, Florida from March 14-18, 2022. The HIMSS Global Health Conference & Exhibition is where professionals throughout the global health ecosystem connect for the education, innovation and collaboration they need to reimagine health and wellness for everyone, everywhere. HIMSS members and healthcare professionals—from CIOs and senior executives to providers and payers to IT consultants and entrepreneurs—attend this influential conference and trade show year after...

HOUSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) — ION Geophysical Corporation (NYSE: IO) announced today that it has entered into a Second Forbearance and Sixth Amendment extension with PNC Bank, National Association (“PNC”), under its Revolving Credit and Security Agreement dated August 22, 2014 (as amended, the “Credit Agreement”), pursuant to which PNC has agreed to waive, through and including March 8, 2022, a cross default that would have occurred under the Credit Agreement by virtue of ION’s missing and still not having paid, the interest payment on the 2025 Notes that was due on December 15, 2021. In addition, ION also announced that it had entered into Amendment No. 1 to the Forbearance Agreement with holders of more than 79% of its 2025 Notes to continue to forbear until March 8, 2022 from enforcing their rights and remedies arising...